Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Boots pharmacists receive £750 pro rata bonus

Boots pharmacists receive £750 pro rata bonus

 The PDA secured a 5% pay award for Boots pharmacists during last year’s pay negotiations with the pharmacy chain

Pharmacists working at Boots have been awarded a non-consolidated £750 pro rata payment, following last year’s successful negotiations between the Pharmacists' Defence Association (PDA) Union and Boots UK.


Announcing this development, the PDA highlighted that the payment recognises the dedication of Boots pharmacists in delivering NHS core and advanced services, including the Pharmacy First Service, Common Ailments Service, Hypertension Case Finding and Pharmacy Contraception Service.

“This bonus is a recent example of the successful collaboration between the PDA and Boots, and how working alongside a trade union can benefit all parties involved,” the associated stated.

As the official union for pharmacists at Boots, the PDA plays a crucial role in negotiating their pay, terms, and conditions.

The PDA’s pay negotiations with the pharmacy chain last year led to a five percent pay increase for Boots pharmacists, which came into effect in November 2023.

The union revealed that discussions for the 2024 pay review are currently underway with Boots.

The PDA also has recognition agreements with other employers, including LloydsPharmacy Healthcare Services and all GP Federations in Northern Ireland.

These agreements enable formal negotiations on pay, terms, and conditions between employees and employers.

Pharmacists interested in establishing a recognition agreement at their workplace are encouraged to contact the PDA Member Support Centre for assistance.

Last month, Boots announced that it would proceed with closing the remaining stores as part of its plan to shut 300 UK pharmacy branches by the summer of 2024.

Last month, Boots confirmed to The Pharmaceutical Journal that it would complete the closure of the remaining stores of its planned programme to shut 300 UK pharmacy branches in the summer of 2024.

In June 2023, Walgreens Boots Alliance, Boots' parent company, announced its decision to close 300 UK pharmacies within a year as part of plans to save US$800m.

Currently, Boots UK operates 2,100 stores across the UK.

In its quarterly financial report released on 27 June 2024, Walgreens Boots Alliance said that part of its cost-cutting measure involved the closure of "up to 650 Boots stores" in the UK. By 31 May 2024, the company had closed 581 of these stores.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less